Release Date: 28/05/14 08:55 Summary: 2014 AGM corporate presentation to shareholders Price Sensitive: No Download Document 410.98KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%